Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4-(1H-indazol-5-yl-amino)-quinazoline compounds as erbB receptor tyrosine kinase inhibitors for the treatment of cancer

4-(1H-indazol-5-yl-amino)-quinazoline compounds as erbB receptor tyrosine kinase inhibitors for the treatment of cancer

US Patent 7820683 · Granted Oct 26, 2010

Estimated economic value: $6,321,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2,6,9-trisubstituted purines2025
POLQ inhibitors2025
Chemical compounds2024
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer2023
[1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative dise2022
Pyridine and pyrimidine derivatives2022
Selective estrogen receptor down-regulators2021
Chemical compounds2021
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer2021
[1,2,4]triazolo[4,3-B]pyridazines for use in the treatment of proliferative dise2020
Chemical compounds2020
Chemical compounds2020